Surgeons divided by prostate cancer debate
With a new prostate cancer study reporting that the “watchful waiting” strategy – operating only after cancer spreads – generally increases risks, the debate over prostate cancer treatments is flaring again.
The study of nearly 700 men, done in Sweden and published in the March 6 edition of the New England Journal of Medicine, divided subjects diagnosed with prostate cancer into two groups: One was observed only, until it showed symptoms. The other underwent surgery as soon as the first trace of cancer was detected.
Dr. Shawn Zimberg is quoted in this Long Island Business News article. To read the article, please click here.
Clinical Trial Underway to Test Potential Prostate Cancer Vaccine
Advanced Radiation Centers of New York (ARC), one of the pre-eminent Radiation Oncology groups in the country, has been selected as the first free-standing radiation facility in New York to participate in a Phase III clinical trial of ProstAtak™, an innovative new vaccine approach for prostate cancer. To read about this new trial, please click here.